TY  - CONF
A1  - Patel, M.
A1  - Kumar, S.
A1  - Balakumar, S.
A1  - Patel, A.
A1  - Bhuvanesh, M.
A1  - Painter, M.
A1  - Rajaraman, Ravishankar
A1  - Hassan, Ahmedali M.
A1  - Padmanaban, Jeya
T1  - A new methodology for determining accident and injury contributing factors, and its application to road accidents on the Mumbai-Pune Expressway
N2  - Road accidents are typically analyzed to address influences of human, vehicle, and environmental (primarily infrastructure) factors. A new methodology, based on a "Venn diagram" analysis, gives a broader perspective on the probable factors, and combinations of factors, contributing both to the occurrence of a crash and to sustaining injuries in that crash. The methodology was applied to 214 accidents on the Mumbai-Pune expressway. Factors contributing to accidents and injuries were addressed. The major human factors influencing accidents on this roadway were speeding (30%) and falling asleep (29%), while injuries were primarily due to lack of seat belt use (46%). The leading infrastructure factor for injuries was impact with a roadside manmade structure (28%), and the main vehicle factor for injuries was passenger compartment intrusion (73%). This methodology can help identify effective vehicle and infrastructure-related solutions for preventing accidents and mitigating injuries in India.
KW  - Autobahn
KW  - Deutschland
KW  - Fahrzeug
KW  - Indien
KW  - Konferenz
KW  - Menschlicher Faktor
KW  - Tödlicher Unfall
KW  - Unfall
KW  - Unfallrekonstruktion
KW  - Untersuchung am Unfallort
KW  - Ursache
KW  - Verfahren
KW  - Verkehrsinfrastruktur
KW  - Verletzung
KW  - Accident
KW  - Accident reconstruction
KW  - Cause
KW  - Conference
KW  - Expressway
KW  - Fatality
KW  - Germany
KW  - Human factor
KW  - India
KW  - Injury
KW  - Method
KW  - On the spot accident investigation
KW  - Transport infrastructure
KW  - Vehicle
Y1  - 2015
UR  - https://bast.opus.hbz-nrw.de/frontdoor/index/index/docId/1514
UR  - https://nbn-resolving.org/urn:nbn:de:hbz:opus-bast-15144
N1  - Außerdem beteiligt: JP Research Inc., Mountain View, California
ER  -